During the past decade, Progressive Medical Research conducted 100 clinical trials. In the 10-year time frame, 100 clinical trials started and 45 clinical trials were completed, i.e. on average, 45% percent of trials that started reached the finish line to date. In the past 5 years, 54 clinical trials started and 34 clinical trials were completed. i.e. 63% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Progressive Medical Research" #1 sponsor was "Eli Lilly and Company" with 11 trials, followed by "Pfizer" with 10 trials sponsored, "Hoffmann-La Roche" with 7 trials sponsored, "Ionis Pharmaceuticals, Inc." with 4 trials sponsored and "Janssen Vaccines & Prevention B.V." with 4 trials sponsored. Other sponsors include 70 different institutions and companies that sponsored additional 61 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Progressive Medical Research" #1 collaborator was "National Institute on Aging (NIA)" with 6 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Alzheimer's Clinical Trials Consortium" with 2 trials as a collaborator, "Biogen" with 2 trials as a collaborator and "Integrium" with 2 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Progressive Medical Research" are "Alzheimer Disease" (22 trials), "Alzheimer's Disease" (7 trials), "Hypertension" (6 trials), "Hyperlipidemia" (4 trials) and "Low Back Pain" (4 trials). Many other conditions were trialed in "Progressive Medical Research" in a lesser frequency.

Most popular intervention types in "Progressive Medical Research" are "Drug" (96 trials), "Biological" (16 trials), "Other" (15 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (59 trials), "placebo" (4 trials), "Crenezumab" (3 trials), "Donanemab" (3 trials) and "Obicetrapib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Progressive Medical Research" are 108 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Progressive Medical Research". undefined are not yet recruiting, 16 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 63 completed trials in Progressive Medical Research, 1 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Progressive Medical Research, 8 "Phase 1" clinical trials were conducted, 47 "Phase 2" clinical trials and 55 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".